Early safety check of AMG 378 in healthy volunteers ends early
NCT ID NCT06910709
First seen Dec 29, 2025 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This early-stage study aimed to check if the experimental drug AMG 378 is safe and tolerable in healthy adults aged 18 to 55. Participants received either single or multiple doses of the drug or a placebo. The study was terminated early, so no results on safety or how the drug behaves in the body are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
-
Orange County Research Center
Lake Forest, California, 92630, United States
Conditions
Explore the condition pages connected to this study.